Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

This study has been completed.

Study NCT00066781 Information provided by National Cancer Institute (NCI)

First Received: August 6, 2003 Last Updated: April 14, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)

Publications:

Holtan SG, Foster NR, Erlichman CE, et al.: Gemcitabine (G) and irinotecan (CPT-11) as first-line therapy for carcinoma (ca) of unknown primary (CUP): An NCCTG phase II trial. [Abstract] J Clin Oncol 26 (Suppl 15): A-13525, 2008.